News from the European Society for Medical Oncology Congress
Copenhagen, 7-11 October 2016
- “ESMO 2016 Press Release: Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression” | 09 Oct 2016
- “ESMO 2016 Press Release: Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression” | 09 Oct 2016